DnB Asset Management
IMCR icon

DnB Asset Management’s Immunocore IMCR Stock Holding History

DnB Asset Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,066
Closed -$454K – 1245
2025
Q4 		$454K Buy
13,066
+4,950
+61% +$175K ﹤0.01% 682
2025
Q3 		$295K Buy
8,116
+488
+6% +$16.6K ﹤0.01% 695
2025
Q2 		$239K Sell
7,628
-3,225
-30% -$100K ﹤0.01% 685
2025
Q1 		$322K Buy
10,853
+555
+5% +$16.6K ﹤0.01% 684
2024
Q4 		$304K Sell
10,298
-70
-0.7% -$2.21K ﹤0.01% 687
2024
Q3 		$323K Buy
10,368
+3,157
+44% +$115K ﹤0.01% 677
2024
Q2 		$244K Buy
7,211
+1,868
+35% +$95.3K ﹤0.01% 684
2024
Q1 		$347K Buy
+5,343
New +$367K ﹤0.01% 671

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

DnB Asset Management's IMCR Position: Q1 2026 in Review

DnB Asset Management sold out of Immunocore (IMCR) in Q1 2026, closing a stake of 13,066 shares — an estimated $454K sold.

DnB Asset Management first reported a position in IMCR in Q1 2024 and held it in 8 quarters. The position peaked at $454K in Q4 2025. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • DnB Asset Management reported no remaining Immunocore position as of Q1 2026 after selling out during the quarter.
  • DnB Asset Management sold 13,066 Immunocore shares in Q1 2026, an estimated $454K.
  • DnB Asset Management first reported a position in Immunocore in Q1 2024 and held it in 8 quarters.
  • DnB Asset Management's Immunocore position peaked at $454K in Q4 2025.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on DnB Asset Management's 13F filing for Q1 2026, filed 14 May 2026.